[1] | “Cardiovascular diseases (CVDs),” Who.int. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). [Accessed: 25-Sep-2024]. |
[2] | S. James Booth, “Fusobacterium infections☆,” in Reference Module in Biomedical Sciences, Elsevier, 2014. |
[3] | Y. W. Han, “Fusobacterium nucleatum Interaction with Host Cells,” Oral Microbial Communities. Wiley, p. 221, 02-Aug-2011. |
[4] | S. Chaushu et al., “Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease,” PLoS Pathog., vol. 8, no. 3, p. e1002601, 2012. |
[5] | J. Zhou, L. Liu, P. Wu, L. Zhao, and Y. Wu, “Fusobacterium nucleatum accelerates atherosclerosis via macrophage-driven aberrant proinflammatory response and lipid metabolism,” Front. Microbiol., vol. 13, 2022. |
[6] | A. L. Truant, S. Menge, K. Milliorn, R. Lairscey, and M. T. Kelly, “Fusobacterium nucleatum pericarditis,” J. Clin. Microbiol., vol. 17, no. 2, pp. 349–351, 1983. |
[7] | M. Febbraio, C. B. Roy, and L. Levin, “Is there a causal link between periodontitis and cardiovascular disease? A concise review of recent findings,” Int. Dent. J., vol. 72, no. 1, pp. 37–51, 2022. |
[8] | H. Liu, Y. Liu, W. Fan, and B. Fan, “Fusobacterium nucleatum triggers proinflammatory cell death via Z-DNA binding protein 1 in apical periodontitis,” Cell Commun. Signal., vol. 20, no. 1, 2022. |
[9] | J. O’Brien, H. Hayder, Y. Zayed, and C. Peng, “Overview of MicroRNA biogenesis, mechanisms of actions, and circulation,” Front. Endocrinol. (Lausanne), vol. 9, 2018. |
[10] | S. Liu et al., “The host shapes the gut Microbiota via fecal MicroRNA,” Cell Host Microbe, vol. 19, no. 1, pp. 32–43, 2016. |
[11] | A. Swidsinski et al., “Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum,” Gut, vol. 60, no. 1, pp. 34–40, 2009. |
[12] | I. Brook, “Fusobacterial infections in children,” Curr. Infect. Dis. Rep., vol. 15, no. 3, pp. 288–294, 2013. |
[13] | L. Wolff, D. Martiny, V. Y. M. Deyi, E. Maillart, P. Clevenbergh, and N. Dauby, “COVID-19-associated Fusobacterium nucleatum bacteremia, Belgium,” Emerg. Infect. Dis., vol. 27, no. 3, pp. 975–977, 2020. |
[14] | P. J. Ford et al., “Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study,” Oral Microbiol. Immunol., vol. 21, no. 4, pp. 206–211, 2006. |
[15] | C. A. Brennan and W. S. Garrett, “Fusobacterium nucleatum — symbiont, opportunist and oncobacterium,” Nat. Rev. Microbiol., vol. 17, no. 3, pp. 156–166, 2019. |
[16] | Y. W. Han, “Fusobacterium nucleatum: a commensal-turned pathogen,” Curr. Opin. Microbiol., vol. 23, pp. 141–147, 2015. |
[17] | S. Hopkins et al., “Oral health and cardiovascular disease,” Am. J. Med., vol. 137, no. 4, pp. 304–307, 2024. |
[18] | “Life’s Essential 8TM Your checklist for lifelong good health,” Heart.org. [Online]. Available: https://www.heart.org/en/healthy-living/healthy-lifestyle/lifes-essential-8. [Accessed: 25-Sep-2024]. |